TE_15271
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1PB1_3end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | -, ESR1 |
| Class | Chimeric, Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 175.83 |
| Counts of samples | TCGA_tumor:155; TCGA_normal:0; GTEx:0 |
| TSS | chr6(+):151643391 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_15271.11 | ESR1 | Chimeric | Non-coding | Non-coding | chr6(+):151643392,151644013,151649693,151649977,151651697,151651796,151656655,151656763,151701875,151702005,151807843,151807863 |
| teRNA_15271.12 | - | Intergenic | Non-coding | Non-coding | chr6(+):151643392,151644013,151649693,151649977,151651697,151651796,151662596,151662616 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
